Atomic Interactions and Profile of Small Molecules Disrupting Protein-Protein Interfaces: the TIMBAL Database

被引:140
作者
Higueruelo, Alicia P. [1 ]
Schreyer, Adrian [1 ]
Bickerton, G. Richard J. [1 ]
Pitt, Will R. [1 ,2 ]
Groom, Colin R. [3 ]
Blundell, Tom L. [1 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England
[2] UCB Celltech, Slough, Berks, England
[3] Cambridge Crystallog Data Ctr, Cambridge, England
基金
英国生物技术与生命科学研究理事会;
关键词
CREDO; database; druggable; drugs; multi-protein complexes; PICCOLO; protein-protein interactions; small molecules; TIMBAL; STRUCTURE-BASED DESIGN; HUMAN-PAPILLOMAVIRUS TYPE-11; E2 TRANSACTIVATION DOMAIN; ZIPA-FTSZ INTERACTION; LIGAND INTERACTION; POTENT INHIBITORS; DRUG CANDIDATES; BCL-2; PROTEINS; LEAD DISCOVERY; BINDING-SITE;
D O I
10.1111/j.1747-0285.2009.00889.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growing evidence of the possibility of modulating protein-protein interactions with small molecules is opening the door to new approaches and concepts in drug discovery. In this paper, we describe the creation of TIMBAL, a hand-curated database holding an up to date collection of small molecules inhibiting multi-protein complexes. This database has been analysed and profiled in terms of molecular properties. Protein-protein modulators tend to be large lipophilic molecules with few hydrogen bond features. An analysis of TIMBAL's intersection with other structural databases, including CREDO (protein-small molecule from the PDB) and PICCOLO (protein-protein from the PDB) reveals that TIMBAL molecules tend to form mainly hydrophobic interactions with only a few hydrogen bonding contacts. With respect to potency, TIMBAL molecules are slightly less efficient than an average medicinal chemistry hit or lead. The database provides a resource that will allow further insights into the types of molecules favoured by protein interfaces and provide a background to continuing work in this area. Access at http://www-cryst.bioc.cam.ac.uk/timbal.
引用
收藏
页码:457 / 467
页数:11
相关论文
共 61 条
  • [31] Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry
    McMillan, K
    Adler, M
    Auld, DS
    Baldwin, JJ
    Blasko, E
    Browne, LJ
    Chelsky, D
    Davey, D
    Dolle, RE
    Eagen, KA
    Erickson, S
    Feldman, RI
    Glaser, CB
    Mallari, C
    Morrissey, MM
    Ohlmeyer, MHJ
    Pan, CH
    Parkinson, JF
    Phillips, GB
    Polokoff, MA
    Sigal, NH
    Vergona, R
    Whitlow, M
    Young, TA
    Devlin, JJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) : 1506 - 1511
  • [32] Targeting protein-protein interactions: Lessons from p53/MDM2
    Murray, Justin K.
    Gellman, Samuel H.
    [J]. BIOPOLYMERS, 2007, 88 (05) : 657 - 686
  • [33] Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XLAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database
    Nikolovska-Coleska, Z
    Xu, L
    Hu, ZJ
    Tomita, Y
    Li, P
    Roller, PP
    Wang, RX
    Fang, XL
    Guo, RB
    Zhang, MC
    Lippman, ME
    Yang, DJ
    Wang, SM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) : 2430 - 2440
  • [34] The Thermodynamics of Protein-Ligand Interaction and Solvation: Insights for Ligand Design
    Olsson, Tjelvar S. G.
    Williams, Mark A.
    Pitt, William R.
    Ladbury, John E.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2008, 384 (04) : 1002 - 1017
  • [35] An inhibitor of Bcl-2 family proteins induces regression of solid tumours
    Oltersdorf, T
    Elmore, SW
    Shoemaker, AR
    Armstrong, RC
    Augeri, DJ
    Belli, BA
    Bruncko, M
    Deckwerth, TL
    Dinges, J
    Hajduk, PJ
    Joseph, MK
    Kitada, S
    Korsmeyer, SJ
    Kunzer, AR
    Letai, A
    Li, C
    Mitten, MJ
    Nettesheim, DG
    Ng, S
    Nimmer, PM
    O'Connor, JM
    Oleksijew, A
    Petros, AM
    Reed, JC
    Shen, W
    Tahir, SK
    Thompson, CB
    Tomaselli, KJ
    Wang, BL
    Wendt, MD
    Zhang, HC
    Fesik, SW
    Rosenberg, SH
    [J]. NATURE, 2005, 435 (7042) : 677 - 681
  • [36] Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer
    Oost, TK
    Sun, CH
    Armstrong, RC
    Al-Assaad, AS
    Betz, SF
    Deckwerth, TL
    Ding, H
    Elmore, SW
    Olejniczak, ET
    Oleksijew, A
    Oltersdorf, T
    Rosenberg, SH
    Shoemaker, AR
    Tomaselli, KJ
    Zou, H
    Fesik, SW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (18) : 4417 - 4426
  • [37] Emerging classes of protein-protein interaction inhibitors and new tools for their development
    Pagliaro, L
    Felding, J
    Audouze, K
    Nielsen, SJ
    Terry, RB
    Krog-Jensen, C
    Butcher, S
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2004, 8 (04) : 442 - 449
  • [38] Identification of a small molecule that inhibits herpes simplex virus DNA polymerase subunit interactions and viral replication
    Pilger, BD
    Cui, C
    Coen, DM
    [J]. CHEMISTRY & BIOLOGY, 2004, 11 (05): : 647 - 654
  • [39] Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: An approach for inhibiting protein-protein interactions
    Raimundo, BC
    Oslob, JD
    Braisted, AC
    Hyde, J
    McDowell, RS
    Randal, M
    Waal, ND
    Wilkinson, J
    Yu, CH
    Arkin, MR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (12) : 3111 - 3130
  • [40] Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2
    Real, PJ
    Cao, YY
    Wang, RX
    Nikolovska-Coleska, Z
    Sanz-Ortiz, J
    Wang, SM
    Fernandez-Luna, JL
    [J]. CANCER RESEARCH, 2004, 64 (21) : 7947 - 7953